Study of Professional and Individual Factors of Covi-19 and Impact on Return to Work

COVID-19 Clinical Trial

— FP-COVID-19  

Official title:

SARS-COV-2 Infection Among Hospital Staff: Study of Professional and Individual Factors of Covi-19 and Impact on Return to Work

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05616663
• Other study ID #: 7954
• Status: Recruiting
• Start date: July 31, 2020
• Est. completion date: December 16, 2023

Study information

• Verified date: December 2023
• Source: University Hospital, Strasbourg, France
• Contact: Maria GONZALEZ, MD, PhD
• Phone: 33 3 88 11 64 66
• Email: maria.gonzalez[@]chru-strasbourg.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Started on January 9, 2020 with the announcement of the discovery of a new SARS-CoV-2 coronavirus, the Covid-19 pandemic is responsible as of June 21, 2020 for 160,377 confirmed cases in France, 29,640 deaths and 9,823 hospitalizations. The Grand Est region is one of the regions in France that was most precociously and strongly affected by the epidemic, in particular the Strasbourg University Hospital. Faced with the heavy use of the healthcare system, hospital staff of all categories are an essential resource to be preserved. Several studies have shown the significant impact of Covid-19 on doctors and caregivers. In order to better protect these personnel and avoid contamination that could be harmful to their health but also because of the consequences in terms of staff, it is necessary to better understand the risk factors for transmission of this infection, the means of protection, the evolution of the disease and the determinants of the return to work. Few studies have explored on such a large workforce and in detail the professional risk factors for developing Covid-19 within different groups of hospital professionals including also non-caregivers and the evolution when returning to work in an outpatient population.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 639
• Est. completion date: December 16, 2023
• Est. primary completion date: December 16, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion criteria:

• Major subject (=18 years old)

• Professionals from the University Hospitals of Strasbourg (HUS)

• Professionals who had been working at the HUS at the time of the diagnosis of SARS CoV-2 infection.

• Subject having not expressed, after being informed, opposition to the reuse of their data for research purposes

Exclusion criteria:

• Subject who expressed their opposition to participating in the study

Related Conditions & MeSH terms

• COVID-19

Locations

Country	Name	City	State
France	Service de Pathologie Professionnelle et Médecine du Travail - CHU de Strasbourg - France	Strasbourg

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	positive RT-PCR test	The presence of SARS CoV 2 infection is assessed by a positive RT-PCR test	one week after infection with Covid-19